These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 786631)

  • 1. Phospholipid and lipopolysaccharide in Proteus mirabilis and its stable protoplast L-form. Difference in content and fatty acid composition.
    Gmeiner J; Martin HH
    Eur J Biochem; 1976 Aug; 67(2):487-94. PubMed ID: 786631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal regulation of the fatty acid composition of lipopolysaccharides and phospholipids of Proteus mirabilis.
    Rottem S; Markowitz O; Razin S
    Eur J Biochem; 1978 Apr; 85(2):445-50. PubMed ID: 206438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerulenin-induced changes in the lipopolysaccharide content and phospholipid composition of Proteus mirabilis.
    Rottem S; Markowitz O; Razin S
    Eur J Biochem; 1978 Apr; 85(2):451-6. PubMed ID: 348472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and fatty acid composition of cytoplasmic membranes from Streptomyces hygroscopicus and its stable protoplast-type L form.
    Hoischen C; Gura K; Luge C; Gumpert J
    J Bacteriol; 1997 Jun; 179(11):3430-6. PubMed ID: 9171384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranes of the protoplast L-form of Proteus mirabilis.
    Kroll HP; Gmeiner J; Martin HH
    Arch Microbiol; 1980 Oct; 127(3):223-9. PubMed ID: 7004376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outer membrane of Proteus mirabilis. II. The extractable lipid fraction and electron-paramagnetic resonance analysis of the outer and cytoplasmic membranes.
    Rottem S; Hasin M; Razin S
    Biochim Biophys Acta; 1975 Feb; 375(3):395-405. PubMed ID: 164215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid composition of lipids of Escherichia coli W 1655 F+ and its stable protoplast type L-form.
    Gumpert J; Schade W; Krebs D; Baykousheva S; Ivanova E; Toshkov A
    Z Allg Mikrobiol; 1982; 22(3):169-74. PubMed ID: 7051584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of quantitative and qualitative antibody-producing cell responses to lipopolysaccharide in cell walls of the bacterial form and in membranes of the protoplast L-form of Proteus mirabilis.
    Karch H; Nixdorff K
    Infect Immun; 1980 Nov; 30(2):349-52. PubMed ID: 7002796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemical composition of the membranes of protoplasts and L-forms of Staphylococcus aureus.
    Ward JB; Perkins HR
    Biochem J; 1968 Jan; 106(2):391-400. PubMed ID: 4295332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificities in the phospholipid and fatty acid composition of the stable protoplast type L-form of Escherichia coli B.
    Gumpert J; Schade W; Krebs B; Baykusheva S; Ivanova E; Toshkov A
    Acta Microbiol Bulg; 1984; 15():17-23. PubMed ID: 6385638
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipids and fatty acids of a moderately halophilic bacterium, No. 101.
    Ohno Y; Yano I; Hiramatsu T; Masui M
    Biochim Biophys Acta; 1976 Mar; 424(3):337-50. PubMed ID: 1259964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMPARISON OF LIPIDS AND LIPOPOLYSACCHARIDE FROM THE BACILLARY AND L FORMS OF PROTEUS P18.
    NESBITT JA; LENNARZ WJ
    J Bacteriol; 1965 Apr; 89(4):1020-5. PubMed ID: 14276089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a stable spheroplast type L-form of Proteus mirabilis D 52 as cell envelope mutant. I. Isolation, growth characteristics, biochemical activities, and sensitivity to bacteriophages.
    Gumpert J; Taubeneck U
    Z Allg Mikrobiol; 1975; 15(6):399-410. PubMed ID: 1105990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Serratia marcescens hemolysin is secreted but not activated by stable protoplast-type L-forms of Proteus mirabilis.
    Sieben S; Hertle R; Gumpert J; Braun V
    Arch Microbiol; 1998 Oct; 170(4):236-42. PubMed ID: 9732437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of polymyxin B resistance in Proteus mirabilis.
    Sud IJ; Feingold DS
    J Bacteriol; 1970 Oct; 104(1):289-94. PubMed ID: 4319722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of enterobacterial common antigen: Proteus mirabilis and its various L-forms.
    Rinno J; Gmeiner J; Golecki JR; Mayer H
    J Bacteriol; 1980 Feb; 141(2):822-7. PubMed ID: 6154039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Proteus mirabilis lipopolysaccharides with different O-polysaccharide structures on the plasma membrane of human erythrocytes.
    Arabski M; Gwoździński K; Sudak B; Kaca W
    Z Naturforsch C J Biosci; 2008; 63(5-6):460-8. PubMed ID: 18669036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous signal peptide processing in fusion interferon synthesis by engineered L-forms of Proteus mirabilis.
    Laplace F; Egerer R; Gumpert J; Kraft R; Kostka S; Malke H
    FEMS Microbiol Lett; 1989 May; 50(1-2):59-63. PubMed ID: 2661322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of induction of enterobacterial AmpC beta-lactamase on cell-wall peptidoglycan, as demonstrated in Proteus mirabilis and its wall-less protoplast L-form.
    Tölg M; Schmidt H; Schierl R; Datz M; Martin HH
    J Gen Microbiol; 1993 Nov; 139(11):2715-22. PubMed ID: 8277255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipid composition of Erysipelothrix rhusiopathiae and its L forms].
    Cherneva E; Todorov TKh
    Vet Med Nauki; 1983; 20(2):20-6. PubMed ID: 6880015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.